October 2, 2014 modus health, llc Names Corporate Board of Advisors

Washington, D.C. October 2, 2014 – modus health, llc, a digital health company focused on providing accurate and actionable physical activity data to inform clinical decision making and improve patient outcomes, announced today the formation of its Corporate Advisory Board with eight key appointments.

“We are honored to have the support, input and commitment from this group of distinguished leaders in health care innovation, policy and finance as members of the modus health corporate advisory board,” commented Doug McCormack, modus health CEO. “The addition of these influential advisors come at a critical stage in our development as we sign key customers and collaboration agreements, and also prepare to support anticipated growth through recent favorable federal reimbursement decisions for modus’ core digital health product, StepWatch™.”

David Albert, MD
David E. Albert, MD is a physician, inventor and entrepreneur who has developed medical technologies and products over the last 30 years, turning a number of those innovations into tech startups. Today, he is a founder of three tech companies, InnovAlarm, Lifetone Technology and AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). Dr. Albert left GE in 2004 as Chief Scientist of GE Cardiology to disrupt several new markets. His latest invention, the iPhone ECG, became a global sensation via a 4-minute YouTube Video in January around the Consumer Electronics. Dr. Albert has 37 issued US patents and has authored or co-authored over 50 scientific abstracts and publications principally in Cardiology literature. Dr. Albert graduated with Honors from Harvard College and from Duke University Medical School.

Richard Barker
Mr. Barker Mr. Barker retired in 2005 from his role at The Capital Group where he had served as vice chairman of Capital Group International Inc. and chairman of Capital International Ltd. and Capital Guardian Trust Company. He was involved with the coordination and management of Capital’s $300 billion global institutional portfolio management business. Mr. Barker serves on the Board of Overseers of the Watson Institute of International Studies at Brown University, and is a trustee of the BASIC Fund. He is on the advisory board of two venture capital funds, and is a former trustee of the California Film Institute, Brown University, the Naval War College Foundation, Marin General Hospital Foundation, and the Branson School (past board president). Mr. Barker graduated from Brown University and served as a Naval Aviation Officer.

Rimas Buinevicius
Mr. Buinevicius is a long-time technology innovator and entrepreneur. He is the former CEO and Chairman of Sonic Foundry, Inc. (NASDAQ:SOFO) a Madison, WI-based technology company leading an effort to transform online education and knowledge training through the use of the Internet. For over 25 years, he has been involved with numerous early stage companies. During his 14-year tenure as CEO of Sonic Foundry, he established a financial network of investors with an interest in early stage technology. He holds a BSEE from Illinois Institute of Technology, an MSEE from the University of Wisconsin-Madison and an Executive MBA from the University of Chicago.

Tim Ehrlich, J.D.
Tim is a partner in Gunderson Dettmer’s Boston office where he focuses on the representation of start-up, emerging growth and public companies throughout the entire corporate lifecycle, from formation through liquidity. Tim has particular expertise in structuring and negotiating strategic alliances, including “bet-the-company” intellectual property collaborations. Prior to joining the firm Tim was previously a corporate counsel for Cisco Systems. Tim received his J.D., cum laude, from Harvard Law School, where he was an editor of the Harvard Journal of Law and Technology and his A.B., summa cum laude, from Princeton University.

Bert Harman
Mr. Harman serves as President/CEO of Data Sciences International, a technology provider of complete systems for monitoring and collecting data including advanced telemetry implants and receivers along with data acquisition and analysis software. Prior to DSI, Mr. Harman served as President and CEO, Americas of Otto Bock HealthCare, a developer and manufacturer of advanced assistive technologies. Mr. Harman spent the first twenty-five years of his career working in 3M’s Industrial, International and Health Care Businesses.

Bob McDonald, MD, MBA
Robert C. McDonald, MD, MBA is the President and Founder of Aledo Consulting, Inc. Prior to this role, he served in a variety of senior medical and operations positions at Anthem Blue Cross and Blue Shield and its predecessor company, The Associated Group. Prior to Anthem, he served for three years at Eli Lilly and Company performing cost effectiveness analyses as part of developmental trials across the United States. Dr. McDonald received his MD from University of Texas Southwestern Medical School and his Masters of Business Administration from the University of Pennsylvania Wharton School of Business.

Chuck O’Neill
Chuck has spent the past 20 years establishing and running new divisions for major corporations and founding new healthcare companies. In 2004, he co-founded Avalon Healthcare Holdings, Inc. a health insurance company offering consumer-directed health plans. Prior to Avalon, Chuck was co-founder and director of Oxford Benefit Management (OBM), a wholly owned subsidiary of Oxford Health Plans. In 1999, he co-founded and served as co-CEO of Tech Health, Inc., a healthcare technology company acquired in 2013 for $150 million. Prior to Tech Health, he served in corporate capacities with PharMerica, Inc. and Oxford Health Plans.

Brad Thompson, J.D.
Brad is a Member of the Firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues. Mr. Thomspon focuses on the federal regulatory requirements—FDA, reimbursement, privacy, and others—that impact remote monitoring, mobile health, HIT, and device interoperability. Mr. Thompson serves as a member of a workgroup, created by the U.S. Department of Health and Human Services and the FCC, focusing on identifying key considerations to improve patient safety and promote innovation in health information technology, including mobile medical applications.

###